
Clinical impact of mucus plugs in bronchiectasis
Mucus plugs in bronchiectasis are associated with worse respiratory symptoms and chronic Pseudomonas aeruginosa infection in a study of 133 adults.

Mucus plugs in bronchiectasis are associated with worse respiratory symptoms and chronic Pseudomonas aeruginosa infection in a study of 133 adults.

AI in COPD diagnosis can support case finding, spirometry interpretation and equity while GOLD 2026 highlights validation and guideline gaps.

Astegolimab for COPD was evaluated in the ALIENTO and ARNASA trials to assess its efficacy and safety in patients with frequent exacerbations.

Maternal smoking and CC16 are linked to impaired lung development, lung function decline and emphysema progression, increasing lifelong COPD risk.

Expiratory flow-volume curve concavity predicts future respiratory symptoms but shows lower discriminatory accuracy for COPD incidence than FEV1/FVC.

Gut-lung axis microbiome analysis in stable COPD reveals distinct gut and lung microbiomes associated with airflow limitation, exacerbations and ICS use

BMI genetic factors and COPD are associated with decreased emphysema and increased airway wall thickness across quantitative and visual imaging phenotypes

En este artículo, les presentamos la Conferencia Magistral Manuel Tapia 2018. Dr. Àlvar Agustí García-Navarro. Celebrada en el 51 Congreso Nacional de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), en Palma de Mallorca, del 31 de mayo al 3 de junio de 2018.

Learn why earlier COPD diagnosis and better clinical control during follow-up are essential to reduce exacerbations, improve quality of life and optimise patient outcomes.

Blood biomarkers including CC16, sRAGE and SPD identify pre-COPD lung function trajectories and may improve early COPD risk detection and prevention.